In the case of the identification of insulin-mediated hypoglycemia, the evaluation of pancreatic neuroendocrine tumors (P-NETs), which represent the most common and worrisome causes of non-diabetic insulin-mediated hypoglycemia, must be considered. The gene discussed is INS; the disease is pancreatic neuroendocrine tumor.